| Financial Year |
March 31 2023 |
| Monetary Funds |
1,697,479,016.60 |
| Held-for-trading Financial Assets |
215,874,034.87 |
| Notes Receivable |
107,888,107.28 |
| Accounts Receivable |
1,097,255,763.69 |
| Advances to Suppliers |
286,679,302.42 |
| Other Receivables |
66,010,416.22 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,159,917,633.52 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
18,764,538.32 |
| Total Current Assets |
4,841,092,025.16 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
22,533,596.18 |
| Investment Properties |
39,035,190.04 |
| Fixed Assetes |
1,045,047,597.42 |
| Under-construction Projects |
21,879,816.53 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
185,040,049.65 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,183,235.77 |
| Deferred Income Tax Assets |
140,795,664.08 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,876,454,278.13 |
| Total Assets |
6,717,546,303.29 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
938,714,611.12 |
| Accounts Payable |
697,800,439.76 |
| Accounts Received In Advance |
1,302,546.00 |
| Employee Compensation Payable |
57,043,755.76 |
| Taxes Payable |
46,332,895.17 |
| Interest Payable |
-- |
| Dividend Payable |
405,000.00 |
| Other payables |
187,782,310.14 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
832,553.39 |
| Other Current Liabilities |
138,359,581.64 |
| Sub-Total of Current Liabilities |
3,340,331,661.76 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
422,346.23 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
56,900,666.35 |
| Total Liabilities |
3,397,232,328.11 |
| Paid-In Capital(Or Share Stock) |
798,073,677.00 |
| Capital Surplus |
1,228,374,056.60 |
| Surplus Reserve |
379,582,986.29 |
| LESS:Treasury Stock |
84,266,609.52 |
| Undistributed Profits |
985,010,494.57 |
| Minority Stockholder's Interest |
10,099,077.54 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,310,214,897.64 |
| Owner's Equity（Stockholder's Equity） |
3,320,313,975.18 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,717,546,303.29 |
